US Medical Aesthetics Market - 2025-2033

The US medical aesthetics market reached US$ 6.71 billion in 2024 and is expected to reach US$ 19.34 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

Medical aesthetics refers to a branch of medicine focused on improving a person's appearance through non-surgical and minimally invasive procedures. These treatments are designed to enhance cosmetic features, reverse signs of aging, and address various skin and body concerns. Medical aesthetics encompasses a wide range of procedures aimed at rejuvenating the skin, improving facial and body contours, and enhancing overall physical appearance, often for aesthetic rather than medical purposes.

Market Dynamics: Drivers & Restraints

Rising Technological Advancements in Medical Aesthetic Devices

The rising technological advancements in medical aesthetic devices are significantly driving the growth of the medical aesthetics market and are expected to continuously drive the market over the forecast period. Laser-based treatments have significantly improved skin resurfacing, acne treatment, pigmentation correction, and tattoo removal. These technologies allow for precise and effective treatments with minimal downtime. Thus, the major players and emerging players in the United States are focusing on the advancements in laser devices, which are accelerating the market.

For instance, in March 2024, Reveal Lasers LLC launched the AlloraPro Laser Workstation, a state-of-the-art device designed for permanent hair reduction and skin rejuvenation treatments. The AlloraPro Laser Workstation combines the power of 755nm Alexandrite and 1064nm Nd: YAG wavelengths to deliver fast and permanent hair reduction. With six ergonomic handpieces, including a 30mm spot size for fast treatments, the device is also equipped to target vascular lesions such as leg veins and facial veins, as well as pigmented lesions and photorejuvenation.

The integration of artificial intelligence (AI) is transforming the way treatments are planned and delivered. AI helps in analyzing skin conditions (e.g., acne, wrinkles) and integrates AI image analysis based on individual skin types and concerns. The use of AI in aesthetic devices is expected to increase patient engagement and improve personalized treatment outcomes, driving higher demand for advanced equipment. Thus, these advancements were made by the market players, driving the market in the United States.

For instance, in September 2024, Perfect Corp. launched its new Skincare Pro Aesthetic Simulator for non-surgical facial treatments. Designed specifically for dermatologists, aestheticians, and beauty professionals, this advanced solution seamlessly integrates AI image analysis and AI deep learning models to accurately simulate and visualize 27 types of non-surgical facial procedures across six facial zones.

High Cost of Aesthetic Procedures

The high cost of aesthetic procedures is a significant barrier to the growth of the US medical aesthetics market. While demand for treatments like Botox, dermal fillers, and body contouring is strong, the financial investment required for these procedures limits their accessibility to a broader consumer base. This pricing issue primarily affects middle-class individuals and those without insurance coverage for elective cosmetic treatments.

For instance, Botox injections typically cost around $300 to $700 per session, while dermal fillers can range from $500 to $2,000 per syringe, depending on the product and area treated. Other aesthetic procedures like CoolSculpting, radiofrequency skin tightening, and laser lipolysis typically range in price from $1,500 to $4,000, depending on the treatment area and the number of sessions required to achieve the desired results. These prices are unaffordable for many consumers, limiting the market to wealthier individuals who can afford ongoing treatments.

Segment Analysis

The US medical aesthetics market is segmented based on product type, application, and end-user.

Product Type:

The facial aesthetic products in the product type segment are expected to dominate with the highest market share.

Facial aesthetics are primarily sought after for anti-aging treatments, such as wrinkle reduction, volume restoration, and skin tightening. The aging population in the US contributes significantly to the demand for facial rejuvenation. Botox and dermal fillers are among the most popular facial treatments for wrinkle reduction and volume restoration. Botox injections are used to treat crow’s feet, frown lines, and forehead wrinkles, while dermal fillers are often used to add volume to areas such as cheeks, lips, and under-eye areas. The rising demand for facial aesthetics in the United States is booming the segment demand and market players' interest in developing products for facial aesthetics.

For instance, in February 2025, Evolus, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Evolysse Form and Evolysse Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse collection. These approvals mark Evolus’ entry into the US HA dermal filler market and solidify the company’s position as a multi-product innovator in aesthetics, expanding Evolus’ total addressable market by 78% to approximately $6 billion.

Competitive Landscape

The major US players in the medical aesthetics market include AbbVie Inc., Merz North America, Inc., Cutera, Inc., Candela Corporation, Cynosure, LLC, Alma Lasers, Mentor Worldwide LLC, Sciton, Bausch Health Companies Inc., Sinclair, and others.

Why Purchase the Report?
• Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.

The US medical aesthetics market report delivers a detailed analysis with 39 key tables, more than 40 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.